vs
Side-by-side financial comparison of Avidia Bancorp, Inc. (AVBC) and Ceribell, Inc. (CBLL). Click either name above to swap in a different company.
Avidia Bancorp, Inc. is the larger business by last-quarter revenue ($26.8M vs $24.8M, roughly 1.1× Ceribell, Inc.). Avidia Bancorp, Inc. runs the higher net margin — 22.9% vs -54.6%, a 77.5% gap on every dollar of revenue. Avidia Bancorp, Inc. produced more free cash flow last quarter ($24.1M vs $-11.0M).
Avidia Bank is an American mutual community bank headquartered in Hudson, Massachusetts. It was founded in 2007 when it was formed by a merger between Hudson Savings Bank and Westborough Bank.
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
AVBC vs CBLL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.8M | $24.8M |
| Net Profit | $5.3M | $-13.5M |
| Gross Margin | — | 87.3% |
| Operating Margin | 33.3% | -58.9% |
| Net Margin | 22.9% | -54.6% |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | $-0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.8M | $24.8M | ||
| Q3 25 | $28.0M | $22.6M | ||
| Q2 25 | $25.9M | $21.2M | ||
| Q1 25 | $22.9M | $20.5M | ||
| Q3 24 | — | $17.2M |
| Q4 25 | $5.3M | $-13.5M | ||
| Q3 25 | $-907.0K | $-13.5M | ||
| Q2 25 | $3.9M | $-13.6M | ||
| Q1 25 | $-11.6M | $-12.8M | ||
| Q3 24 | — | $-10.4M |
| Q4 25 | — | 87.3% | ||
| Q3 25 | — | 88.3% | ||
| Q2 25 | — | 88.1% | ||
| Q1 25 | — | 87.9% | ||
| Q3 24 | — | 87.3% |
| Q4 25 | 33.3% | -58.9% | ||
| Q3 25 | -7.0% | -64.8% | ||
| Q2 25 | 19.4% | -70.5% | ||
| Q1 25 | -72.0% | -69.3% | ||
| Q3 24 | — | -57.8% |
| Q4 25 | 22.9% | -54.6% | ||
| Q3 25 | -3.2% | -59.6% | ||
| Q2 25 | 15.0% | -64.4% | ||
| Q1 25 | -50.5% | -62.4% | ||
| Q3 24 | — | -60.6% |
| Q4 25 | — | $-0.35 | ||
| Q3 25 | $-0.05 | $-0.37 | ||
| Q2 25 | — | $-0.38 | ||
| Q1 25 | — | $-0.36 | ||
| Q3 24 | — | $-1.85 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $275.0M | $159.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $379.0M | $155.3M |
| Total Assets | $2.8B | $195.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $275.0M | $159.3M | ||
| Q3 25 | $208.3M | $168.5M | ||
| Q2 25 | $592.5M | $177.4M | ||
| Q1 25 | — | $182.7M | ||
| Q3 24 | — | $14.1M |
| Q4 25 | $379.0M | $155.3M | ||
| Q3 25 | $372.0M | $164.1M | ||
| Q2 25 | $191.4M | $172.2M | ||
| Q1 25 | $186.1M | $180.9M | ||
| Q3 24 | — | $-136.0M |
| Q4 25 | $2.8B | $195.8M | ||
| Q3 25 | $2.8B | $199.5M | ||
| Q2 25 | $3.0B | $207.7M | ||
| Q1 25 | $2.7B | $213.5M | ||
| Q3 24 | — | $47.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.4M | $-10.8M |
| Free Cash FlowOCF − Capex | $24.1M | $-11.0M |
| FCF MarginFCF / Revenue | 89.9% | -44.2% |
| Capex IntensityCapex / Revenue | 16.0% | 0.7% |
| Cash ConversionOCF / Net Profit | 5.32× | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.2M | $-41.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.4M | $-10.8M | ||
| Q3 25 | $24.1M | $-11.1M | ||
| Q2 25 | $-2.3M | $-7.5M | ||
| Q1 25 | $-2.2M | $-11.4M | ||
| Q3 24 | — | — |
| Q4 25 | $24.1M | $-11.0M | ||
| Q3 25 | $23.3M | $-11.5M | ||
| Q2 25 | $-3.3M | $-7.6M | ||
| Q1 25 | $-3.9M | $-11.6M | ||
| Q3 24 | — | — |
| Q4 25 | 89.9% | -44.2% | ||
| Q3 25 | 83.2% | -50.8% | ||
| Q2 25 | -12.8% | -35.9% | ||
| Q1 25 | -16.9% | -56.4% | ||
| Q3 24 | — | — |
| Q4 25 | 16.0% | 0.7% | ||
| Q3 25 | 3.1% | 1.6% | ||
| Q2 25 | 3.7% | 0.3% | ||
| Q1 25 | 7.2% | 0.7% | ||
| Q3 24 | — | — |
| Q4 25 | 5.32× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.60× | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVBC
Segment breakdown not available.
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
